Publications Office of the EU
European sales and use of antimicrobials for veterinary medicine
DisplayCustomHeader
MyPortal
English
BasketSummary
Web Content Display (Global)
Publication Detail Actions Portlet

Utilities

Publication Detail Actions Portlet
 Rate this publication
custom-survey-notification
Publication Detail Portlet

Publication detail

Home

European sales and use of antimicrobials for veterinary medicine

Annual surveillance report for 2023

Publication metadata

The first European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) annual surveillance report, featuring 2023 data, marks a significant milestone in the EU's efforts to monitor antimicrobial consumption in animals. For the first time, data collection and reporting of antimicrobial sales and use in animals were conducted under Article 57 of Regulation (EU) 2019/6. In 2024, 29 reporting countries — 27 EU countries, Iceland and Norway — reported 2023 data to the European Medicines Agency (hereinafter 'the Agency' or EMA) on the volume of sales of antimicrobial veterinary medicinal products (VMPs) and on the use of antimicrobial medicinal products in animals under this legal framework. It was also the first time countries reported antimicrobial use data to the Agency separately for cattle, pigs, chickens, and turkeys, marking a significant step towards obtaining more granular information on antimicrobial consumption by species. Previously, the Agency published annual reports under the voluntary European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project, which ended with the publication of 2022 sales data from 31 European countries (United Kingdom and Switzerland do not report to ESUAvet).
View more
View less
ISBN 978-92-9155-141-5
DOI 10.2809/4487470
Catalogue number TC-01-25-021-EN-N
PDF
ISSN ISBN 978-92-9155-141-5 DOI 10.2809/4487470 Catalogue number TC-01-25-021-EN-N
  • Released on EU publications website:
Publication Viewer

Document viewer

Pop up window annotations